LUCENCE HEALTH INC.

In News

Singapore cancer-testing startup sets sights on US expansion - Nikkei Asia

Nikkei Asia - Dec 16, 2025

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services - Mayo Clinic News Network

Mayo Clinic News Network - Jan 10, 2025

AstraZeneca and Lucence Collaborate in South-East Asia to bring HRD Testing to Ovarian Cancer Patients to guide PARPi Treatment - AstraZeneca

AstraZeneca - Nov 12, 2021

Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests - Business Wire

Business Wire - Dec 10, 2020

Min-Han Tan: Lucence’s 7-year journey covered by Forbes Asia - Oncodaily

Oncodaily - Jun 21, 2024

First Asian firm to clinch US Medicare approval: How Lucence flies the S’pore flag with cancer test kit - The Straits Times

The Straits Times - Jul 31, 2024

Liquid Biopsy Market Size, Share, Demand | CAGR of 13.1% - Market.us

Market.us - May 10, 2019

Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening - Business Wire

Business Wire - Mar 24, 2021

Singapore start-ups leverage the diaspora to spread their wings in the US - The Straits Times

The Straits Times - Dec 17, 2023

Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market | - openpr.com

openpr.com - Jul 06, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment